Qbiogene becomes part of MP Biomedicals
MP Biomedicals (formerly ICN Biomedicals) is pleased to announce the acquisition of Qbiogene creating a single world-class biomedical organization with the merger of life science and diagnostics product offerings. With the inclusion of Qbiogene products and expertise, MP Biomedicals has expanded its industry leading portfolio of products and solutions, and will continue to provide scientists and researchers with innovative tools and superior service.
MP Biomedicals is a global corporation headquartered in Irvine, California. MP Biomedicals has operations in Northern California, New York, Ohio, Japan (Tokyo), Belgium (Brussels), Germany (Eschwege), Australia (Seven Hills), Russia (Moscow) and Singapore. Now with the addition of Qbiogene, MP Biomedicals will also have offices in France (Strasbourg), Canada (Montreal) and Carlsbad, California. For more information, visit www.mpbio.com or www.qbiogene.com.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.